* * 100102 - DrugBank - - - - 1 - - 5 2 3-4 - 2013-11-27 81373985 81173568 NECT-11-0605 2008BAI51B01 2011-6 CXTD-11 2013-JYBZZ-XS-110 * Tel 010 84738620 E-mail wangyun @ bucm. edu. cn * 010 84738620 E-mail yjqiao@ 263. net Tel 2417
1 1. 1 - - 7 - - 2 2. 1-50% Drugbank 1 Reactome HPRD P < 0. 05 GeneCards Stitch - - DrugBank 8 1. 2-2010 1 - - - - 9 - - CNKI 1980 13 9 10 - - SAS8. 2 Statistics Analysis System Enterprise Miner - - 2 - - 2 2 1. 3 Table 1 The relationship of herbal function-property-pharmacol- 11 ogy 12 - / / 25 36 9 75 8 6-1 1 - - 1 Fig. 1 Target intersection of analgesic and anti-inflammatory 2 2. 2 2418
2 Table 2 Common targets for anti-inflammatory and analgesic P08908 HTR1A 5-hydroxytryptamine 1A receptor P15121 AKR1B1 aldose reductase P19793 RXRA retinoic acid receptor RXR-alpha P23219 PTGS1 prostaglandin G / H synthase 1 P25024 CXCR1 high affinity interleukin-8 receptor A P27361 MAPK3 mitogen-activated protein kinase 3 P28221 HTR1D 5-hydroxytryptamine 1D receptor P28222 HTR1B 5-hydroxytryptamine 1B receptor P35228 NOS2 nitric oxide synthase inducible P35354 PTGS2 prostaglandin G / H synthase 2 P41595 HTR2B 5-hydroxytryptamine 2B receptor Q03181 PPARD peroxisome proliferator-activated receptor delta Q9Y5Y4 GPR44 putative G-protein coupled receptor 44 2 2 3 3 3 2 TP53 CX- CR4 14 2 Fig. 2 Functional network of invigorating blood circulation PPARD 15 F2 2419
3 Table 3 Targets interaction of promoting blood circulation and liver cancer PTGS2 PTGS2 NOS2 NOS2 AKR1B1 AKR1B1 GPR44 CXCR4 GPR44 CCL5 PPARD PROX1 PPARD NR0B2 PPARD SRC 5HT2B F2 5HT2B GNRHR PGH2 TP53 5HT1B CXCR4 5HT1B CCL5 5HT1D CXCR4 5HT1D CCL5 MK03 MAP2K1 MK03 TP53 MK03 TGIF1 MK03 CASP9 MK03 STAT3 MK03 STMN1 MK03 SRC MK03 SP1 MK03 INSR MK03 RAF1 MK03 MYC CXCR1 CXCR4 CXCR1 CCL5 RXRA IGFBP3 RXRA NFKB1 RXRA PARP1 5HT1A CXCR4 5HT1A CCL5 4 4 Table 4 Screening of safflower active ingredient group for antihepatoma - NFKB1 - CCL5 - PTGS2 NFKB1 NOS2 INSR NFKB1 MYC PTGS2 PPARD - PTGS2 NFKB1 STAT3 NOS2 GNRHR - TP53 CASP9 PARP1 PTGS2 MYC - INSR - PTGS2 AKR1B1 SRC NOS2 18 H PTG2 MKO3 TP53 CXCR4 19 20 NOS2 PPARD 3 16 meta 17 1. J. 2012 46 2 79. 2. 2. 3 J. 2004 45 4 310. 3. J. 1993 13 6 330. Stitch 4. J. 2008 10 5 105. 2420
5. J. 2007 19 6 558. J. 2010 12 5 764. 6. SMMC-7721 J. 2011 39 5 32. 7. - J. γ PPARγ J. 2005 25 2011 22 7 1568. 8. M. 16. 2002. 9. M. 2006. 10. M. Meta J. 2005. 11 Wang Y. Entity grammar systems a grammatical tool for studying the hierarchical structures of biological systems J. Bull Math Biol 2004 66 3 447. 12 Yan J. TCM grammar systems an approach to aid the interpretation of the molecular interactions in Chinese herbal medicine J. J Ethnopharmacol 2011 137 1 77. 13. 1 30. 14. CXCR4 J. 2012 41 2 131. 15. 5 413. J. 2002 17 4 228. 17. 2008 8 1 21. 18. J. 2009 24 23 2034. 19. D. 2012. 20. J. 2010 39 Analysis on anti - hepatoma effect of medicine invigorating blood circulation and eliminating blood stasis based on warm- pungent- liver efficiency network GU Hao MA Li YUAN Bin ZHANG Yan-ling WANG Yun * QIAO Yan-jiang * Information Engineering Research Center for Traditional Chinese Medicines Beijing University of Chinese Medicine Beijing 100102 China Abstract Objective The efficiency network is a complicated network for revealing the efficient mechanism of traditional Chinese medicines TCMs and relations among efficiencies. The efficiency-property relations were used to establish a warm-pungent-liver efficiency network to explain the principle of treating hepatoma with medicines invigorating blood circulation and eliminating blood stasis. Safflower a warm-pungent medicine distributing along the live meridian was taken for example to discuss the efficiency network' s application in the identification of active ingredients of TCMs and the combination. Method In the early stage of this study combined warm-pungent-liver medicines distributed along the liver meridian and invigorating blood circulation and eliminating blood stasis were taken as the study objects to collect the pharmacological effect data of warm-pungent-liver medicines and obtain the pharmacological effect combinations with the highest blood circulation-invigorating association by the association rules and the chi-square test. The pharmacological target data recorded in the DrugBank database is used to establish the warm-pungent-liver efficiency network according to the principle line of efficiency-property-pharmacology-target-protein interaction under the background of the protein interaction network. Result The blood circulation-invigorating medicines could directly treat hepatoma by impacting protooncogene cancer suppressor gene cell apoptosis and anti-inflammation and indirectly treat hepatoma by resisting coagulation and adhesion regulating local blood circulation preventing cancer cell metastasis and enhancing the tissues' sensitivity to the anticancer drugs. Among the active ingredients of safflower screened based on the blood circulation-invigorating network targets carthamin yellow quercetin and luteolin have been proved to have the anti-hepatoma effect in literatures which indicated the reliability of this study's results and the purpose of the efficiency network. Conclusion The efficiency network is an effective method for revealing the TCM' s mechanism and lays a foundation for discovering key active ingredients of TCMs for treating specific diseases. Key words invigorate blood circulation efficiency network hepatoma doi 10. 4268 /cjcmm20141313 2421